{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:53:36Z","timestamp":1785419616173,"version":"3.56.0"},"reference-count":76,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder caused by mutations in the NF1 gene, typically diagnosed during early childhood and characterized by significant phenotypic heterogeneity. Despite advancements in next-generation sequencing (NGS), the diagnostic process remains challenging due to the gene\u2019s complexity, high mutational burden, and frequent identification of variants of uncertain significance (VUS). This review explores the emerging role of artificial intelligence (AI) in enhancing NF1 variant detection, classification, and interpretation. A systematic literature search was conducted across PubMed, IEEE Xplore, Google Scholar, and ResearchGate to identify recent studies applying AI technologies to NF1 genetic analysis, focusing on variant interpretation, structural modeling, tumor classification, and therapeutic prediction. The review highlights the application of AI-based tools such as VEST3, REVEL, ClinPred, and NF1-specific models like DITTO and RENOVO-NF1, which have demonstrated improved accuracy in classifying missense variants and reclassifying VUS. Structural modeling platforms like AlphaFold contribute further insights into the impact of NF1 mutations on neurofibromin structure and function. In addition, deep learning models, such as LTC neural networks, support tumor classification and therapeutic outcome prediction, particularly in NF1-associated complications like congenital pseudarthrosis of the tibia (CPT). The integration of AI methodologies offers substantial potential to improve diagnostic precision, enable early intervention, and support personalized medicine approaches. However, key challenges remain, including algorithmic bias, limited data diversity, and the need for functional validation. Ongoing refinement and clinical validation of these tools are essential to ensure their effective implementation and equitable use in NF1 diagnostics.<\/jats:p>","DOI":"10.3390\/genes16050560","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T11:46:19Z","timestamp":1746618379000},"page":"560","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Role of Artificial Intelligence in Identifying NF1 Gene Variants and Improving Diagnosis"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0988-0602","authenticated-orcid":false,"given":"Vasiliki Sofia","family":"Grech","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, School of Health and Care Sciences, University of West Attica, GR-12243 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleomenis","family":"Lotsaris","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, General Hospital of Athens: \u201cEvaggelismos\u201d, GR-10676 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theano Eirini","family":"Touma","sequence":"additional","affiliation":[{"name":"Child and Adolescent Psychiatrist, General Hospital \u201cAsklepieio Voulas\u201d, GR-16673 Voula, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Kefala","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Health and Care Sciences, University of West Attica, GR-12243 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8806-281X","authenticated-orcid":false,"given":"Efstathios","family":"Rallis","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Health and Care Sciences, University of West Attica, GR-12243 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Mirzaa, G., and Amemiya, A. (2019). Neurofibromatosis 1. GeneReviews, University of Washington."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00019052-200404000-00004","article-title":"Recent advances in neurofibromatosis type 1","volume":"17","author":"Arun","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PAP.0000000000000197","article-title":"Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms","volume":"25","author":"Longo","year":"2018","journal-title":"Adv. Anat. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jid.2014.465","article-title":"Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland","volume":"135","author":"Uusitalo","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: An international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bergoug, M., Doudeau, M., Godin, F., Mosrin, C., Vall\u00e9e, B., and B\u00e9n\u00e9detti, H. (2020). Neurofibromin Structure, Functions and Regulation. Cells, 9.","DOI":"10.3390\/cells9112365"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Upadhyaya, M., and Cooper, D.N. (2012). NF1 Germline and Somatic Mosaicism. Neurofibromatosis Type 1: Molecular and Cellular Biology, Springer.","DOI":"10.1007\/978-3-642-32864-0"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41525-024-00425-9","article-title":"Prenatal diagnosis for neurofibromatosis type 1 and the pitfalls of germline mosaics","volume":"9","author":"Pacot","year":"2024","journal-title":"NPJ Genom. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ejhg.2014.145","article-title":"Neurofibromatosis type 1 molecular diagnosis: What can NGS do for you when you have a large gene with loss of function mutations?","volume":"23","author":"Pasmant","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2018.10.006","article-title":"Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA","volume":"395","author":"Tsipi","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pediatrneurol.2023.08.036","article-title":"Evaluation of Molecular and Clinical Findings in Children With Neurofibromatosis Type 1: Identification of 15 Novel Variants","volume":"149","author":"Bildirici","year":"2023","journal-title":"Pediatr. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jmoldx.2023.04.003","article-title":"Detecting Low-Variant Allele Frequency Mosaic Pathogenic Variants of NF1, TSC2, and AKT3 Genes from Blood in Patients with Neurodevelopmental Disorders","volume":"25","author":"Kim","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41525-021-00258-w","article-title":"Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq","volume":"6","author":"Koster","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00439-021-02363-3","article-title":"Classification of NF1 microdeletions and its importance for establishing genotype\/phenotype correlations in patients with NF1 microdeletions","volume":"140","author":"Cooper","year":"2021","journal-title":"Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00439-021-02410-z","article-title":"Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants","volume":"141","author":"Cooper","year":"2022","journal-title":"Hum. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.23929","article-title":"Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: Genotype-phenotype study in neurofibromatosis type 1","volume":"41","author":"Koczkowska","year":"2020","journal-title":"Hum. Mutat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41586-021-04043-8","article-title":"Disease variant prediction with deep generative models of evolutionary data","volume":"599","author":"Frazer","year":"2021","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-023-00451-1","article-title":"SpliceAI-visual: A free online tool to improve SpliceAI splicing variant interpretation","volume":"17","author":"Filser","year":"2023","journal-title":"Hum. Genom."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ha, C., Kim, J.W., and Jang, J.H. (2021). Performance Evaluation of SpliceAI for the Prediction of Splicing of NF1 Variants. Genes, 12.","DOI":"10.3390\/genes12091308"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Huber, C.D., Kim, B.Y., and Lohmueller, K.E. (2020). Population genetic models of GERP scores suggest pervasive turnover of constrained sites across mammalian evolution. PLoS Genet., 16.","DOI":"10.1371\/journal.pgen.1008827"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lu, Q., Hu, Y., Sun, J., Cheng, Y., Cheung, K.H., and Zhao, H. (2015). A statistical framework to predict functional non-coding regions in the human genome through integrated analysis of annotation data. Sci. Rep., 5.","DOI":"10.1038\/srep10576"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"D835","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: Improvements to accessing data","volume":"48","author":"Landrum","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Liu, Y., Yeung, W.S.B., Chiu, P.C.N., and Cao, D. (2022). Computational approaches for predicting variant impact: An overview from resources, principles to applications. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.981005"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Choon, Y.W., Choon, Y.F., Nasarudin, N.A., Al Jasmi, F., Remli, M.A., Alkayali, M.H., and Mohamad, M.S. (2023). Artificial intelligence and database for NGS-based diagnosis in rare disease. Front. Genet., 14.","DOI":"10.3389\/fgene.2023.1258083"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajhg.2018.08.005","article-title":"ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants","volume":"103","author":"Alirezaie","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Accetturo, M., Bartolomeo, N., and Stella, A. (2020). In-silico Analysis of NF1 Missense Variants in ClinVar: Translating Variant Predictions into Variant Interpretation and Classification. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030721"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Carter, H., Douville, C., Stenson, P.D., Cooper, D.N., and Karchin, R. (2013). Identifying Mendelian disease genes with the variant effect scoring tool. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-S3-S3"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12031-024-02271-x","article-title":"Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches","volume":"74","author":"Chen","year":"2024","journal-title":"J. Mol. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jmb.2010.09.027","article-title":"Cysteine Function Governs Its Conservation and Degeneration and Restricts Its Utilization on Protein Surfaces","volume":"404","author":"Marino","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: A policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"W344","DOI":"10.1093\/nar\/gkw408","article-title":"ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules","volume":"44","author":"Ashkenazy","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yang, E.-W., and Velazquez-Villarreal, E. (2025). AI-HOPE: An AI-Driven conversational agent for enhanced clinical and genomic data integration in precision medicine research. medRxiv.","DOI":"10.1101\/2024.11.27.24318113"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100701","DOI":"10.1016\/j.gimo.2023.100701","article-title":"O48: DITTO4NF: In silico classification and prioritization of likely pathogenic variants for NF1 using explainable machine learning","volume":"1","author":"Worthey","year":"2023","journal-title":"Genet. Med. Open"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Pagel, K.A., Kim, R., Moad, K., Busby, B., Zheng, L., Hynes-Grace, M., Tokheim, C., Ryan, M., and Karchin, R. (2019). OpenCRAVAT, an open source collaborative platform for the annotation of human genetic variation. bioRxiv.","DOI":"10.1101\/794297"},{"key":"ref_39","unstructured":"Bidollahkhany, M., Atasoy, F., Abedini, E., Davar, A., Hamza, O., Sefao\u011flu, F., Jafari, A., Yal\u00e7\u0131n, M., and Abdellatef, H. (2023). GENIE-NF-AI: Identifying Neurofibromatosis Tumors using Liquid Neural Network (LTC) trained on AACR GENIE Datasets. arXiv."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"The AACR Project GENIE Consortium, Andr\u00e9, F., Arnedos, M., Baras, A.S., Baselga, J., Bedard, P.L., Berger, M.F., Bierkens, M., Calvo, F., and Cerami, E. (2017). AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov., 7, 818\u2013831.","DOI":"10.1158\/2159-8290.CD-17-0151"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bonetti, E., Pellegatta, S., Rosati, N., Eoli, M., and Mazzarella, L. (2025). RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity. medRxiv.","DOI":"10.1101\/2025.01.06.25320039"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajhg.2021.03.010","article-title":"Machine learning-based reclassification of germline variants of unknown significance: The RENOVO algorithm","volume":"108","author":"Favalli","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104847","DOI":"10.1016\/j.ejmg.2023.104847","article-title":"Reassessment of the NF1 variants of unknown significance found during the 20-year activity of a genetics diagnostic laboratory","volume":"66","author":"Martorana","year":"2023","journal-title":"Eur. J. Med. Genet."},{"key":"ref_44","unstructured":"FDA (2017). FDA Warning: Avoid Using Bone Growth Products in Children, FDA."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/hmg\/ddt333","article-title":"Hyperactive Ras\/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice","volume":"22","author":"Sharma","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Carlier, A., Vasilevich, A., Marechal, M., de Boer, J., and Geris, L. (2018). In silico clinical trials for pediatric orphan diseases. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-20737-y"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhang, Y., Zhu, K., Li, J., Guan, Y., He, X., Jin, X., Bai, G., and Hu, L. (2022). Clinical characteristics and in silico analysis of congenital pseudarthrosis of the tibia combined with neurofibromatosis type 1 caused by a novel NF1 mutation. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.991314"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1212\/WNL.0000000000012436","article-title":"Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use","volume":"97","author":"Bettegowda","year":"2021","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","article-title":"p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas","volume":"23","author":"Pinna","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","article-title":"Emerging genotype-phenotype relationships in patients with large NF1 deletions","volume":"136","author":"Mautner","year":"2017","journal-title":"Hum. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41439-024-00299-4","article-title":"Genotypes and phenotypes of neurofibromatosis type 1 patients in Japan: A Hereditary Tumor Cohort Study","volume":"11","author":"Futagawa","year":"2024","journal-title":"Hum. Genome Var."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cge.12498","article-title":"The natural history of spinal neurofibromatosis: A critical review of clinical and genetic features","volume":"87","author":"Ruggieri","year":"2015","journal-title":"Clin. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Napolitano, F., Dell\u2019Aquila, M., Terracciano, C., Franzese, G., Gentile, M.T., Piluso, G., Santoro, C., Colavito, D., Patane, A., and De Blasiis, P. (2022). Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent NF1 Gene Variants and Correlations with Neurocognitive Phenotype. Genes, 13.","DOI":"10.3390\/genes13071130"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nbt.4235","article-title":"A universal SNP and small-indel variant caller using deep neural networks","volume":"36","author":"Poplin","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41467-019-09025-z","article-title":"A multi-task convolutional deep neural network for variant calling in single molecule sequencing","volume":"10","author":"Luo","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Boza, V., Brejova, B., and Vinar, T. (2017). DeepNano: Deep recurrent neural networks for base calling in MinION nanopore reads. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178751"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Anzar, I., Sverchkova, A., Stratford, R., and Clancy, T. (2019). NeoMutate: An ensemble machine learning framework for the prediction of somatic mutations in cancer. BMC Med. Genom., 12.","DOI":"10.1186\/s12920-019-0508-5"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Spinella, J.F., Mehanna, P., Vidal, R., Saillour, V., Cassart, P., Richer, C., Ouimet, M., Healy, J., and Sinnett, D. (2016). SNooPer: A machine learning-based method for somatic variant identification from low-pass next-generation sequencing. BMC Genom., 17.","DOI":"10.1186\/s12864-016-3281-2"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/bioinformatics\/bty303","article-title":"GARFIELD-NGS: Genomic vARiants FIltering by dEep Learning moDels in NGS","volume":"34","author":"Ravasio","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Singh, A., and Bhatia, P. (2019). Intelli-NGS: Intelligent NGS, a deep neural network-based artificial intelligence to delineate good and bad variant calls from IonTorrent sequencer data. bioRxiv.","DOI":"10.1101\/2019.12.17.879403"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/bioinformatics\/btu703","article-title":"DANN: A deep learning approach for annotating the pathogenicity of genetic variants","volume":"31","author":"Quang","year":"2015","journal-title":"Bioinformatics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nmeth.3547","article-title":"Predicting effects of noncoding variants with deep learning-based sequence model","volume":"12","author":"Zhou","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41591-018-0279-0","article-title":"Identifying facial phenotypes of genetic disorders using deep learning","volume":"25","author":"Gurovich","year":"2019","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Boudellioua, I., Kulmanov, M., Schofield, P.N., Gkoutos, G.V., and Hoehndorf, R. (2019). DeepPVP: Phenotype-based prioritization of causative variants using deep learning. BMC Bioinform., 20.","DOI":"10.1186\/s12859-019-2633-8"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41436-019-0439-8","article-title":"Xrare: A machine learning method jointly modeling phenotypes and genetic evidence for rare disease diagnosis","volume":"21","author":"Li","year":"2019","journal-title":"Genet. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Yang, Z., Liu, X., Xu, H., Teschendorff, A.E., Xu, L., Li, J., Fu, M., Liu, J., Zhou, H., and Wang, Y. (2024). Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma. Commun. Biol., 7.","DOI":"10.1038\/s42003-024-06488-9"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"D1151","DOI":"10.1093\/nar\/gkae1008","article-title":"sc2GWAS: A comprehensive platform linking single cell and GWAS traits of human","volume":"53","author":"Yin","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Xing, Y., Yang, K., Lu, A., Mackie, K., and Guo, F. (2024). Sensors and Devices Guided by Artificial Intelligence for Personalized Pain Medicine. Cyborg Bionic Syst., 5.","DOI":"10.34133\/cbsystems.0160"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.stem.2024.06.007","article-title":"Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening","volume":"31","author":"Zhou","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00403-025-03896-7","article-title":"METTL3-modified exosomes from adipose-derived stem cells enhance the proliferation and migration of dermal fibroblasts by mediating m6A modification of CCNB1 mRNA","volume":"317","author":"Zhou","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-023-01199-y","article-title":"ClinVar and HGMD genomic variant classification accuracy has improved over time, as measured by implied disease burden","volume":"15","author":"Sharo","year":"2023","journal-title":"Genome Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13073-024-01392-7","article-title":"Using multiplexed functional data to reduce variant classification inequities in underrepresented populations","volume":"16","author":"Dawood","year":"2024","journal-title":"Genome Med."},{"key":"ref_74","unstructured":"(2025, April 30). Franklin by Genoox. Available online: https:\/\/franklin.genoox.com\/about-franklin."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40246-023-00472-w","article-title":"Community data-driven approach to identify pathogenic founder variants for pan-ethnic carrier screening panels","volume":"17","author":"Einhorn","year":"2023","journal-title":"Hum. Genom."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41746-025-01454-z","article-title":"A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification","volume":"8","author":"Wei","year":"2025","journal-title":"NPJ Digit. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/5\/560\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:28:49Z","timestamp":1760030929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/5\/560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":76,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["genes16050560"],"URL":"https:\/\/doi.org\/10.3390\/genes16050560","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}